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(From the Department  of Pathology,  New York University School of Medicine,  New York 10016) 
Repletion  of the  thymic  lymphoid  compartment  after  irradiation  depends 
upon the existence of the stem cells in the hematopoietic tissues (1-3).  Neither 
the origin nor the state of differentiation of these precursor cells has been firmly 
established.  Their ultimate progenitor appears to be a pluripotential  stem cell 
(CFUs) ~ among whose progeny are counted T and B lymphocytes as well as the 
erythroid  and  myeloid  elements  (4,  5).  The  subsequent  development  of this 
pluripotent  stem  cell  appears  to  involve  several  discrete  stages  of differen- 
tiation. 
Indirect  evidence  suggests  that the thymus precursor or prothymocyte is a 
specialized cell,  committed to thymocyte differentiation and discrete from both 
the precursors of B  cells and the pluripotential stem cell  (6-8).  We have devel- 
oped a quantitative assay for this cell and have previously used it to explore the 
kinetics  of repopulation of the murine thymus after T-irradiation  (9).  We now 
use  this  assay  to  examine  the  state  of differentiation  of the  hematopoietic 
precursor.  Prothymocytes are found amongst the "null cell" population of both 
the spleen and bone marrow but bear surface antigens reactive with rabbit anti- 
mouse brain antisera. 
Materials and Methods 
Mice-Source and  Care.  Female  mice,  5-  to  6-wk  old,  were  obtained  from  Texas  Inbred, 
Houston,  Texas  (AKR/Texas,  hereafter  designated  as AKR/T), and  Cumberland  View Farms, 
Clinton, Tenn.  (AKR]Cumberland,  hereafter designated as AKR/C). AKR/T mice bear the Thy- 
1.1  (0AKR) alloantigen while AKR/C anomalously bear Thy-l.2 (0C3H)  (10).  All animals were 
housed three to four per cage, fed commercial mouse food, and maintained on acidified chlorinated 
water. 
Antisera and Complement.  Antisera were produced by the reciprocal immunization of AKR/T 
and AKR/C mice with thymocytes of the appropriate strains as previously described (9). 
Rabbit antiserum to mouse immunoglobulin (RaMIG) was obtained from rabbits  immunized 
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~Abbreviations  used  in  this paper:  B  cells,  Igopositive peripheral  lymphocytes;  BM,  bone 
marrow; BSA, bovine serum albumin; CFUs, spleen colony-forming pluripotential stem cells; CR, 
complement receptor; EAC, sheep cells coated with 19S antibody and complement components; Fc 
receptor, a receptor for the portion of the Ig molecule bearing isotypic specificities; GaRIG, goat 
antiserum to rabbit immunoglobulin; [~H]TdR, tritiated thymidine; KLH, keyhole limpet hemocy- 
anin; RaMIG, rabbit antiserum to mouse Ig; T cells; Thy-l-positive peripheral lymphocytes; TL, 
thymus leukemia antigen (a differentiation antigen of mouse cortical thymocytes). 
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with insoluble keyhole limpet hemocyanin (KLH); mouse anti-KLH antibody (antigen-antibody) 
complexes in complete Freund's adjuvant and absorbed with mouse thymocytes before use. Rabbit 
antisera to mouse brain were prepared by injecting AKR/C brain emulsified in complete Freund's 
adjuvant as described by Golub  (11).  The sera were absorbed with an equal volume of packed 
mouse erythrocytes and had a cytotoxic titer of h 1,000 against mouse thymocytes when tested with 
guinea pig complement (C). In some experiments the serum was also absorbed with a  liver cell 
membrane fraction. 
Goat anti-rabbit immunoglobulin (GaRIG) was purchased from Miles Laboratories, Inc., Miles 
Research Div.,  Kankakee,  Ill.  Rabbit serum selected for low toxicity to mouse thymocytes was 
used as a  source of C in alloantiserum-mediated cytotoxicity; guinea pig serum was used as a  C 
source in hetero-antiserum-mediated killing. 
Cell Suspensions.  Cell suspensions were prepared in tissue culture medium RPMI1640 (Grand 
Island Biological Co., Grand Island, N. Y.) containing 50 U/ml penicillin and 50 #g/ml streptomy- 
cin and supplemented with bovine serum albumin (BSA, 7 mg/ml obtained from Miles Laborato- 
ries,  Inc.,  Miles  Research  Div.)  as  previously  described  (9),  and  maintained in  this medium 
throughout the subsequent manipulations. 
Irradiation.  A 137Cs source (Model M Gammator; Radiation Machinery Corp., Parsippany, N. 
J.) delivering 630 rads/min was used to irradiate the mice used in these experiments. 
Origin  of Cells  Repopuiating  the  Thymus.  The  assay  for  cells  of donor  origin  has  been 
described in detail previously  (9).  It is a  cytotoxic test making use of the differences in Thy-1 
antigens in AKR mice purchased from different sources. AKR/C (Thy-l.2) mice are irradiated (760 
rads) and injected with hematopoietic cells from AKR/T  (Thy-l.1) mice.  At various times after 
irradiation and cell transfer, the proportion of replicating thymocytes bearing the donor type Thy- 
1 antigen is determined by selectively killing the cells bearing one of the two Thy-1 alleles. The 
viability of the remaining cells is assessed by measuring their incorporation of ([3H]TdR) into 
DNA and this is compared to the incorporation by the whole population. The proportion of cells 
bearing the donor Thy-1 allele is calculated as follows: 
([3H]TdR incorporation after elimination of host cells -  background) 
% Cells of donor origin = 
(total [3 H]TdR incorporation -  background) 
Isopycnic  Density Gradient and Isokinetic Velocity  Gradient Centrifugations.  Discontinuous 
gradients of BSA were prepared and harvested as previously described (7). 
For velocity sedimentation,  l0  s spleen cells in 2 ml of Puck's saline were separated in 50-ml 
centrifuge tubes containing shallow BSA gradients as described by Pretlow and Boone (12). They 
were centrifuged for 18  min at  120 rpm in a  model  PR2  Centrifuge (IEC).  2-ml fractions were 
collected from the bottom of the tube. When necessary fractions were pooled to provide sufficient 
cells for a  transfer. 
CFUs.  CFUs were determined as described by Till and McCulloch (13).  Macroscopic colonies 
were counted on the 8th day after 890 rads in spleens fixed in Bouin's solution. 
Antibody-Mediated  Cytotoxicity.  A  two-stage  assay  in  which the  cells are  incubated with 
antiserum for 60 min at 4°C, washed, and then incubated with C for 45 min at 37°C was used. Anti- 
Thy-1 and RaMIG sera were used at a concentration of 0.1 ml/10  T cells. Rabbit antisera to mouse 
brain absorbed with erythrocytes had residual toxicity for all mouse cells when used at greater 
than 0.02 ml/107 cells. When further absorbed with liver cell membranes it could be used at the 
same  concentration as the other sera.  After treatment with C  the cells were washed twice in 
medium  and  then  adjusted  to  the  appropriate  concentration  on  the  basis  of viable  cells  as 
determined by trypan blue exclusion. 
Differential Adhesiveness.  Spleen cells were fractionated on glass wool  and nylon fiber col- 
umns according to the method of Trizio and Cudkowicz  (14)  in RPMI  1640.  107 cells from each 
fraction were injected into irradiated AKR/C mice and the extent ofthymic repopulation measured 
2 wk later. 
Rosette Techniques.  Three different erythrocyte preparations were used to prepare rosettes 
with different populations of lymphocytes. First, sheep erythrocytes coated with 19S antibody and 
C  (EAC) prepared by the method of Bianco et al.  (15)  were used to remove C  receptor-positive 
(CR+) lymphocytes.  Rosettes were made by incubating nucleated cells with EAC at 37°C for 45 
min with continuous agitation.  When velocity sedimentation was used to separate the rosettes 
from the nonrosetting cells EAC and nucleated cells were mixed at a ratio of 1 erythrocyte (RBC) ROSS S.  BASCH  AND JULIAN  L.  KADISH  407 
per nucleated cell, but when density gradients were used 50-100 RBC were added per nucleated 
celt. 
Sheep  RBC  coated with the globulin fraction of sheep anti-rabbit serum were used to form 
rosettes with RaMIG-treated cell suspensions as described by Parrish et al.  (16).  100 RBC were 
added  per nucleated  cell.  This technique selectively produces  rosettes  among cells with high 
concentrations of immunoglobulin on their surface. 
Finally, ox RBC heavily coated with mouse 7S anti-ox RBC antibodies were used to prepare 
rosettes  with  cells  having  a  receptor  for  the  Fc  portion  of the  immunoglobulin  molecule  as 
described by Ramasamy and Munro (17).  50:100 RBC were added per nucleated cell. 
In most experiments cells forming rosettes were separated from those that did not by centrifu- 
gation  at  2,000 g  for  20 min  over  a  layer  of Ficoll-Hypaque  (density  1.075)  which had been 
prewarmed to 20°C (18). The cells to be tested for rosette formation were first layered onto a Ficoll- 
Hypaque gradient and centrifuged as described to remove dense cells and RBC. These had been 
shown to be devoid of repopulating activity and were discarded. The cells that accumulated at the 
interface were  washed  and then used to prepare rosettes.  Rosettes,  plus a  few residual dense 
nucleated  cells  pellet  in  the  Ficoll-Hypaque  leaving the  nondense,  nonrosetting cells  at  the 
interface. The RBC in the rosettes were lysed with Tris-buffered isotonic ammonium chloride and 
the remaining nucleated cells injected. 
Self-sterilization via [aH]TdR Incorporation.  AKR/T spleen cells were prepared as a single cell 
suspension and incubated for 3 h at a concentration of 6.25 ×  10  e cells/ml in medium containing 1.6 
pCi/ml [~H]TdR (43 Ci/mmol; New England Nuclear, Boston, Mass.). The cells were washed three 
times in large volumes of medium and injected into irradiated AKR/C mice. Controls were incu- 
bated in the same medium containing a  1,000-fold excess of unlabeled thymidine. Aliquots were 
removed for counting and autoradiography performed as previously described. 
Results 
Physical Properties of the Thymocyte Precursor 
RELATIVE DENSITY.  A  single cell suspension of AKR/T spleen cells was 
fractionated according to  buoyant  density by  centrifugation on  a  four-step 
discontinuous BSA  density gradient.  Cells  from each interface band were 
injected into irradiated AKR/C mice and 12 days later their thymuses were 
assayed for AKR/T-type thymocytes. The results are shown in Table I. Layers 
2 and 3 (those cells that did not pass through 25 and 27% BSA, respectively) are 
enriched for the thymocyte  precursor compared to unfractionated spleen cells. 
Layers 1 and 4 are partially depleted of these cells. Spleen cells dense enough 
to pellet 29% BSA (nearly 40% of  the cells recovered) are totally depleted of  the 
thymocyte  precursor. Identical results are found with bone marrow (BM) cells. 
Similar results could be obtained using a continuous BSA gradient. In this 
medium the  model  density of the  thymocyte progenitor is  1.068  +__  0.003. 
Significant enrichment of prothymocytes could also be achieved by floatation 
above  a  dense  (sp  gr  1.075) layer of Ficoll-Hypaque.  The  interface layer 
contains 30% of the nucleated cells of the spleen and 80% of the thymocyte 
precursor activity. 
SIZE OF THE PRECURSOR.  An estimate of the size of the prothymocyte was 
made on the basis of its sedimentation behavior in isokinetic velocity gradients 
of BSA in Puck's saline. Fig.  1 shows the size-distribution analysis obtained 
using low angle light scattering of cells from a normal AKR/T mouse spleen. 
The peak at the left is produced by RBC, while the major peak is produced by 
small and medium sized lymphocytes. The most rapidly sedimenting fractions 
were pooled to provide sufficient cells for a transfer. The median size in each 
fraction was determined and these are indicated on the figure. The ability of 408  PROPERTIES  OF  HEMATOPOIETIC  THYMOCYTE  PRECURSORS 
TABLE  [ 
Relative Density of the BM-Derived Thymocyte Precursor: Separation on a 
Discontinuous BSA Gradient 
% Donor type thymocytes (at 
Source of cells  % of cells* recovered 
12 days ±  SD) 
Unfractionated normal  -  6.6  ±  2.1 
BM cells 
Layer 15  7.8  5.1  ±  0.6 
Layer 2  9.6  11.4  -+ 2.3 
LayEr 3  13.6  9.5  ±  3.8 
Layer 4  29.6  3.4 ±  0.7 
Pellet  39.7  0.0  ±  1.1 
* 63.8% of the cells applied to the gradient were recovered. 
$ Layer 1 was obtained at the interface above a  23% BSA layer. Layers 2-4 were found at the 
interface of a 23-25, 25-27, and 27-29% BSA, respectively. 5 x  10  e cells were injected per mouse. 
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Fro.  1.  Relative size of the hematopoietic thymocyte precursor. The figure illustrates the 
relative size distribution of  normal spleen cells as measured by low angle light scattering in 
a Cytograph (Bio/Physics Systems Inc., Mahopac, N. Y.). The abscissa is an arbitrary scale 
representing the  magnitude  of the  light scattering produced by  the  cells.  The  arrows 
indicate the median size of the cells found in the various fractions of an isokinetic velocity 
sedimentation experiment and  the  insert  indicates the  extent  of thymic  repopulation 
achieved 14 days after the injection of 107 cells from each fraction. 
the cells in fraction to serve as a  source of thymocyte precursors was tested. 
The results are shown in the insert to the figure. Both the small and very large 
fractions are depleted of  thymic precursors. Fractions E and F are significantly 
enriched in precursors. The majority of prothymocytes are thus similar in size 
to medium to large lymphocytes (10-15  pm in diameter). 
Biologic Properties of Hematopoietic Thymic Precursors 
CORTISONE SENSITZVITY.  The  sensitivity of the  thymocyte precursor  to  a 
large dose of hydrocortisone succinate was tested by two methods: by treatment 
of the recipients with the drug after injection of the donor cells, and by treat- 
ment of the donor animals before the cells were removed. In mice receiving 5 or 
10 mg of hydrocortisone immediately after the injection of 107 bone marrow cells ROSS S.  BASCH AND JULIAN L.  KADISH  409 
TABLZ II 
Cortisone Sensitivity of the Thymocyte Precursor 
% Donor type thymocytes (_+ SD) on day 
Test animal treatment* 
14 after irradiation and grafting 
Experiment 1 
10  7  Normal AKR/T  BM  cells 
10  7  BM  cells  plus 5 mg HC$ 
10  7  BM  cells  plus 10 mg HC$ 
Experiment 2 
5 × 10  6  normal AKR/T  spleen cells 
5 x  10  6 Cortisone-treated§  AKR/T 
spleen cells 
47.1  ±  11.0 
38.1  ±  1.5 
34.6  ±  7.8 
4.7  _+  2.3 
6.6  _+  1.3 
* All recipients were AKR/C mice irradiated with 760 rads before injection of 
cells. 
HC, hydrocortisone succinate (Upjohn Co., Kalamazoo, Mich.)injected S.C. 
2 h after injection of BM cells. 
§ AKR/T donors were treated with 5 mg hydrocortisone succinate subcutane- 
ously 16 h before the spleen cells were prepared. 
(see Table II,  top) thymic size at  14 days is not altered and the percentage of 
dividing cells of the donor type is only slightly less than in the untreated control. 
Pretreatment of the donors with cortisone (Table II, bottom) produces a modest 
enrichment of the thymocyte precursors. 16 h after the administration of 5 mg of 
hydrocortisone succinate spleen size is reduced by 50%.  If prothymocytes are 
insensitive  to  cortisone,  the  cell  suspension  prepared  from  such  cortisone- 
treated animals should be approximately 100% enriched in this activity. A 40% 
enrichment  was observed.  Both experiments,  therefore,  indicate that the pre- 
cursors are relatively but not completely resistant to hydrocortisone. 
MITOTIC ACTIVITY.  The sensitivity of the thymocyte precursor to self sterili- 
zation  by high  specific activity  [3H]TdR Cthymidine  suicide")  was used  as a 
measure of their turnover rate.  AKR/T BM cells were incubated with [~H]TdR 
for  3  h  in  vitro.  The  cells  were  washed  and  injected  into  irradiated  AKR/C 
recipients.  2 wk later the  thymuses  of these animals  were examined  for the 
presence of cells bearing the Thy-1 antigen characteristic of the donor cells. The 
results are shown in experiment  1 of Table III. The effect of this treatment of 
CFUs is shown for comparison.  The proportion of donor-type cells was reduced 
by only 19% indicating that few of these cells are dividing [doubling time(TD) 50- 
60 h].  As expected CFUs were unaffected by this treatment  (19). 
SENSITIVITY TO T-IRRADIATION.  The ability of AKR/T BM cells, irradiated in 
vitro, to serve as thymocyte precursors was tested. The results are shown in the 
second experiment of Table III. The lethal dose for 90% (LDgo) of the precursor, 
estimated from a  semilogarithmic  plot of the data is 400 R but this is greatly 
influenced  by the  large  threshold  effect observed.  Calculation  of D37  in  the 
exponential portion of the curve gives a value of 75 R. Under similar conditions 
an LD9o of 120 R and a  D37 of 47 R have been calculated for cortical thymocytes 
(20). 
ADHERENCE  TO  GLASS  WOOL  AND NYLON  FIBER COLUMNS.  The adherence  of 
prothymocytes to glass wool and washed nylon fibers was examined by sequen- 410  PROPERTIES  OF  HEMATOPOIETIC  THYMOCYTE  PRECURSORS 
TABLE  Ill 
Sensitivity of thymocyte precursors to 3HTdR "Suicide" and to ~-Irradiation 
% Thymocytes with do- 
CFU* (__ SD)  nor$ type Thy-1 antigen 
(+-  SD) 
Control  BM  28.3 ± 2.6  32.9  _-.  1.2 
BM incubated  with  [3H]TdR  26.2  ± 2.5  26.5  ± 1.2 
Irradiation  dose  to donors§ 
marrow (in  vitro)  in  rads 
0  -  25.9 _+ 0.8 
70  -  28.5  ±  2.7 
140  -  24.7  ±  2.3 
210  -  21.6 ±  1.9 
350  -  14.7  ±  1.1 
420  -  7.3  ±  0.9 
490  -  2.4  ±  0.6 
*  CFUs  were  counted  9  days  after  the  transfer  of  2.5  × 10  s  cells  to  AKR/T  mice  which 
had  received  820  rads  on  day 0. (Six  mice  per  group.) 
Measured 14  days  after  the  transfer  of  5 × 10  e  BM cells  to  AKR/C mice  which had 
received  720  rads  on day  0. (Five  mice  per  group.) 
§  Incubated  as  described  in  text.  During the  incubation  the  cells  incorporated  1.4 × 
105  dpm of  [3H]TdR  per  108  cells  into  TCA precipitable  material.  Autoradiographs 
made from aliquots  of  the preparation  showed that  6.2% of  the cells  had been 
labeled.  Each  labeled  cell  therefore  incorporated  an  average  of  2.3  dpm. 
tially  passing a suspension of  AKR/T  spleen cells  through a glass wool column 
and then a nylon fiber  column (14).  The results of  these experiments are shown 
in Table IV. Approximately half  of  the cells  applied to the glass wool columns 
are recovered in the nonadherent fraction. All thymocyte precursor activity 
present in the original suspension is recovered in this nonglass-adherent frac- 
tion. The cells in this fraction were then applied to a nylon wool column. 
Slightly less  than one-third of  the cells  eluted in the nonadherent fraction.  85% 
of  these cells  are Thy-1 positive as  judged by their sensitivity  to alloantisera to 
Thy-l.1. The concentration of  thymocyte precursors in this fraction is signifi- 
cantly less  than the concentration in the sample applied  to  the column, indicat- 
ing that many precursors are retained by the column. 
In a separate experiment the possibility  of recovering these adherent stem 
cells  was tested  and these  results are  also shown in  Table IV. The distribution of 
cells  on  the  two columns was essentially  the  same as  in  the  previous  experiment. 
Nylon wool-adherent cells  were recovered by removing the fibers  from the 
column and  "combing" them in  the  presence  of  a large  volume of  Puck's  saline G. 
After several washes nearly three-quarters of  the adherent cells  are recovered. 
These cells  are not enriched in their  content of  prothymocytes. Thus, although 
nonadherent to glass wool, the precursors are found in both the adherent and 
nonadherent fractions after passage through nylon fibers. 
Surface Membrane Properties of Prothymocytes 
THY-1  (0)  ANTIGEN.  Although  not  a  uniquely  thymocyte  antigen,  the  pres- 
ence of Thy-1  is a  consistent  and  well-characterized  property  of thymic  lympho- 
cytes  (21,  22).  Since  thymopoietin  and  other  thymic  factors  induce  the  appear- ROSS  S.  BASCH  AND JULIAN  L.  KADISH  411 
TABLE IV 
Adherence  of Thymocyte Precursors from Spleen  to Glass and Nylon Fiber Columns 
Number 
Cells transferred*  %  Repopulation  %  of  Original 
(cells  bearing do-  sample re- 
Treatment  nor type Thy-1 an-  covered 
tigen +- SD) 
l0  T  Unfractionated  6.7 -+ 2.1  100 
10  ~  Nonadherent to glass wool  11.7 _+ 1.2  49.6 
l0  T  Nonadherent to both glass  7.1 _+ 1.0  16.4 
and nylon  wool 
2 × 10  T  Nonadherent  to glass wool  39.5 -+ 3.3  61.8 
2 × 107  Nonadherent  to both glass  39.2 -+ 4.6  18.3 
and nylon  wool 
2 x 107  Eluted from  nylon  fiber  28.1 -  2.2  29.5 
* AKR/T  spleen cells  were transferred  to irradiated (760 rads) AKR/C  recipients and the propor- 
tion of  donor-type cells  in the thymus estimated 14 days later. 
ance  of this  antigen  in  hematopoietic  cells,  the  possibility  that  thymocyte 
precursors possess significant quantities of Thy-1 before being subject to thymic 
influence seems remote. Nevertheless it was investigated by exposing the AKR/ 
T donor spleen and marrow cells to high concentrations of anti-Thy-1.1 antisera 
and C before injecting them into irradiated AKR/C mice. The results are shown 
in the first experiment in Table V. As a control, other spleen and BM cells were 
exposed to antisera specific for the Thy-l.2 antigen which is never expressed on 
these cells. The extent of proliferation of thymocytes derived from precursors 
treated with either antiserum is essentially identical, indicating that prothymo- 
cytes do not express significant quantities of Thy-1 antigen on their surface. 
This is in agreement with previously published data (6, 7). 
MOUSE BRAIN-ASSOCIATED THYMIC ANTIGENS.  Golub and Day (11,  23) have 
demonstrated that the immunization of rabbits with mouse brain leads to the 
production of antibodies against a  variety of antigens found on hematopoietic 
cells. The predominant antibody is one reactive with thymocytes. Appropriately 
absorbed  sera  retain  their  cytotoxicity for  thymocytes and  T  cells  but  are 
uureactive with B lymphocytes. Thymic repopulation is almost totally abolished 
when spleen or bone marrow suspensions are treated with absorbed rabbit anti- 
mouse brain (exp. 2, Table V). Thymocytes, splenic T cells, and prothymocytes 
are equally susceptible to this antiserum. 
BRAIN-ASSOCIATED STEM CELL ANTIGEN.  Golub  (24) has  also reported that 
absorption of anti-brain  sera  with thymocytes produces a  reagent capable of 
reacting  specifically with  the  colony-forming stem  cell  normally present  in 
hematopoietic tissues.  A  thymocyte-absorbed anti-brain  serum  (i.e.,  an  anti- 
stem  cell  antiserum)  was  prepared  as  described by  Golub and  tested for its 
ability to eliminate that thymocyte repopulating capacity of spleen and  BM 
cells. The results are included in experiment 2 of Table V. At the dilution used, 
this  antiserum  is  unreactive with  thymocytes or splenic lymphocytes in  the 
cytotoxic test yet it retains its capacity to react with the thymocyte precursor. 
Dilutions of this antiserum were tested for their anti-prothymocyte activity and 
compared with similar dilutions of antiserum to mouse brain which had not 412  PROPERTIES  OF  HEMATOPOIETIC  THYMOCYTE  PRECURSORS 
TABLe. V 
Antigenic Properties of the Hematopoietic Thymocyte Precursor: Sensitivity to Antisera 
Against Thy-1, Mouse Brain, and Immunoglobulin 
Antiserum 
% Repopulation produced by: 
Spleen cells  Bone marrow cells 
Anti-Thy-l.2  7.2  _+  2.1"  5.1  _  2.75 
Anti-Thy-l.1  6.5  _+  1.9  6.3  +_  0.7 
Normal rabbit serum  7.0  _+  1.2§  12.4  _+  1.711 
Rabbit anti-mouse brain  0.4  _+  0.2  2.4  +_  1.0 
Rabbit anti-mouse brain  2.1  _  1.7  1.0  _+ 0.8 
(thymus absorbed) 
Normal rabbit serum  8.9  _+  0.8*  5.8  _+  0.75 
RaMIG  8.3  _+  1.6  6.1  _+  1.2 
All results are given as the arithmetic mean of quadruplicate determination _+  SD. 
* Measured 14 days after 10  ×  106 spleen cells. 
5 Measured 12 days after 5  x  106 BM cells. 
§ Measured 12 days after 50  x  10  e spleen cells. 
II Measured 12 days after 10  x  106 BM cells. 
been absorbed with thymocytes. Absorption with thymocytes reduces the titer 
against prothymocytes by four- to eightfold but cytotoxic activity against these 
cells is clearly retained by dilutions of sera which are totally devoid of cytotoxic- 
ity for more mature numbers of the Thy-l-positive peripheral lymphocyte (T- 
cell) lineage. 
Surface Immunoglobulin.  Although cortical thymocytes and peripheral T 
cells lack readily detectable surface immunoglobulin the status of the precursor 
cell  is  unclear.  Neonatal  thymocytes have  been  claimed  to  be  strongly Ig 
positive (25) and murine T-cell precursors have been reported to be retained by 
anti-Ig columns (26). The presence of Ig on prothymocytes would have profound 
implications for our understanding of the development of differentiated immune 
function. Mouse thymocyte precursors were tested for the presence of surface Ig 
by two different methods. First, an attempt was made to deplete spleen and BM 
suspensions of prothymocytes by treating them with a  polyvalent rabbit anti- 
immunoglobulin serum and C. The results are shown in experiment 3 of Table 
V.  No  reduction  in  repopulating  activity  was  produced by  treatment  with 
RaMIG although more than 90% of the Ig-positive cells (as measured by direct 
immunofluorescence) were killed in  the procedure. An additional  attempt to 
demonstrate Ig-positive thymocyte precursors was made using the "rosetting" 
method of Parish et al.  (16) in  which Ig-bearing mouse cells are coated with 
RaMIG and then allowed to form rosettes with sheep RBC coated with anti- 
rabbit immunoglobulin. The rosettes are separated from other lymphocytes by 
sedimentation through a dense layer of Ficoll-Hypaque. BM cells depleted of Ig- 
positive cells by this  method are also  enriched for,  rather than depleted of, 
prothymocytes (Table VI), strongly suggesting that these cells lack significant 
quantities of surface immunoglobulin. 
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TABLE  VI 
Surface Properties  of the Hematopoietic  Thymocyte Precursor: Ability of 
Cells Expressing IG, CR, or Fc Receptors,  to Repopulate the Thymus of 
Irradiated mice 
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%  Donor type cells*  found after  the injection  of: 
Spleen cells$  BM cells§ 
Unseparated  5.3 _+ 0.7  3.0 -+ 0.8 
CR+  1.2 _+ 0.6  1.3 -+ 0.5 
CR-  5.4 _+ 0.2  4.5 -+ 0.6 
Fc+  0.5 _+ 1.2  ND11 
Fc-  8.6 -+ 1.7  ND 
Ig+  ND  0.9  -+ 0.6 
Ig-  ND  3.9  -+ 0.7 
* Results  are the mean % as determined in quadruplicate determinations _  SD. 
$ Measured  14 days after the transfer of 5 × 10  6 cells. 
§ Measured  12 days after the transfer of 2 × 10  6 cells. 
IIND, not done. 
¶ All of the separations used in this experiment were performed with cells separated 
by the rosetting techniques described under Materials and Methods. 
their  surfaces  a  receptor  for  the  third  component  of C  (15).  This  receptor  is 
absent from T cells and thymocytes and as shown in Table VI is also absent from 
their hematopoietic precursor.  As indicated,  both  BM and splenic CR-positive 
cells fail to serve as thymocyte precursors. Conversely, the CR-negative popula- 
tion is enriched in precursor activity. 
B  lymphocytes and  macrophages  (27-29)  also  bear  a  receptor  that  enables 
them to bind 7S antibodies via the Fc portion of the Ig molecule. A receptor with 
similar  binding  properties  has  been  found  on  a  subset  of T  cells  (30).  This 
receptor is not detectable on prothymocytes. The data (Table VI) show that "Fc- 
negative" cells are an enriched source of prothymocyte precursors. 
Discussion 
The cells that repopulate the thymus of an irradiated  mouse are of hemato- 
poietic origin. These prothymocytes are relatively large cells with a low buoyant 
density  and  do not  adhere  to  glass.  Unlike  their  progeny they  are  relatively 
resistant to the cytolytic effects of corticosteroids and T-irradiation.  The major- 
ity of the population does not appear to be mitotically active when prepared from 
normal  mice.  Neither the  Thy-1  alloantigen  characteristic  of thymocytes and 
thymus-derived  cells,  nor  a  variety of markers generally  associated  with  Ig- 
positive peripheral lymphocytes (B cells) (including surface Ig, Fc receptor, and 
the CR) can be detected. The hematopoietic precursors do bear on their surface, 
antigens that react with antisera against mouse brain. At least two specificities 
appear to be involved; one of these is found on mature thymocytes and can be 
removed  by  absorption  with  cortical  thymocytes.  The  other  remains  after 
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Cells that act as thymocyte  precursors or prothymocytes  have been described 
in other contexts. The cells that populate the embryonic thymic rudiment are 
generally believed to be immigrants from a hematopoietic source (31, 32). We 
believe the migratory cells which we are studying are the adult equivalent of 
these embryonic cells.  The lymphoid cells which appear in  the embryonic 
thymus lack the differentiation antigens characteristic of adult thymus and 
therefore resemble cells described herein (33). Direct comparison of the proper- 
ties of the cells colonizing the embryonic thymus with those serving this role in 
the adult is technically difficult. 
Loor  and  Roelants  and  their  associates  (34-36)  have  presented indirect 
evidence for the existence of a  ~'pre-thymic T  cell." The cells that they de- 
scribed  react  with  antisera  to  mouse  brain  (and  are  called  "weak"  theta 
positives by them) and anti-TL antisera but not with antisera against immu- 
noglobulins. They are present in neonatally thymectomized mice and in con- 
genitally athymic mice homozygous for the nude gene, born of homozygous 
nude mothers. No formal evidence for the precursor role of these cells has been 
adduced but the authors argue that their thymic cell characteristics and their 
presence in athymic mice "makes it tempting to consider them a prethymo- 
cyte." We think it highly probable that the cells that we have characterized are 
identical with those described by Loor  and Roelants.  Questions about the 
presence of low levels of Thy-1 and thymus leukemia (TL) antigens on their 
surface are difficult to resolve. The weak theta-positive cells of Roelants et. al. 
(35, 36) were generally detected by indirect immunofluorescence  using an anti- 
mouse brain  serum as  the  primary reagent.  Despite extensive absorption, 
reagents of this type almost certainly contain many specificities including 
gangliosides (37), T25 protein (38), and the uncharacterized antigen(s) present 
on B cells (39) and stem cells. The question is in part moot since all agree that 
the thymic precursor reacts with anti-mouse brain sera.  Furthermore, the 
presence of small amounts of theta alloantigen and TL antigen on the precur- 
sor population cannot be excluded by our methodology. The efficiency of C- 
mediated cytolysis in eliminating a  specific population depends upon many 
factors including the concentration of antigen present on the cell (40). 
Komuro and Boyse (6)  and Basch and Goldstein  (7) have used the term 
~'prothymocyte" to designate the cells that respond to the presence of thymic 
hormones or nonspecific inducing agents, by expressing thymic differentiation 
antigens.  Scheid et al.  (8)  have presented some,  and we will  shortly offer 
extensive evidence, that the inducible cells can serve as thymic progenitors in 
a repopulation assay. 
The assay used in the experiments presented in this paper measures the 
precursors  of Thy-l-positive cortical thymocytes. It  does  not  measure the 
development of functional T cells.  EI-Arini and Osoba  (41) have used a func- 
tional  test  (mixed leukocyte reactivity) to  describe  a  low  density,  Thy-1- 
resistant,  nonreactive cell found in  BM  which could develop into a  Thy-1- 
positive mixed leukocyte-reactive cell in an irradiated host.  Although their 
data did not indicate that thymic passage was necessary for the maturation of 
those cells, we believe them to be the same as the cells measured in our assay. 
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columns of glass beads coated with the mouse immunoglobulin alone or in 
combination with RaMIG, selectively removed T-cell precursors as indicated 
by depressed graft-vs.-host and/or helper activity in irradiated and repopu- 
lated mice. Although the effect  was not seen in all experiments they concluded 
that the thymic precursor was either Ig or Fc positive. We cannot explain the 
discrepancy between their results and our own except to note that different 
assays  were used  and  that  they did  not  rule  out the  possibility  that  the 
functional activities observed were due to the presence of cells descended from 
Fc-positive T cells in the original marrow samples (41). 
Our assay does not distinguish between functionally or antigenically dis- 
crete subsets  of thymocytes or T  cells  (42-44).  Although all  of these cells 
presumably arise from a common precursor there is little evidence as to when 
in their life history commitment to their ultimate fate occurs. It is possible 
that this occurs early in their development, perhaps during their nomadic 
prethymic existence.  While  this  would not  vitiate  the  general description 
which we have attempted, it would add the further complexity that our data 
may be  describing the  aggregated properties  of an  already heterogeneous 
population. 
The data presented and the work cited above clearly indicate the existence of 
cells capable of serving as the progenitors of cortical thymocytes. We believe 
that  the  majority of the  cells measured in  the  assay are  committed cells, 
destined for no other role but maturation into thymocytes  and thymus-derived 
cells.  It is not possible at this time to eliminate totally the possibility that 
these cells are "pro-immunocytes," capable of differentiating into either T or B 
cells depending on the environment in which they find themselves. Although 
they have been the subject of much discussion, little evidence has been pre- 
sented which indicates that such cells actually exist. It is true that the precur- 
sors of both T and B cells are both found amongst the "null" cells of the spleen 
(45) and share many physical properties (46). It is also true that cells simultane- 
ously expressing both T- and B-cell markers do exist (36, 47, 48) indicating that 
the developmental programs are not mutually exclusive. On the other hand, B- 
cell progenitors have a  different tissue distribution than prothymocytes (46). 
They also appear to become committed to immunoglobulin production before 
they express it on their surface (49, 50), while prothymocytes  bear receptors and 
antigens  associated with the T-cell lineage.  The question remains, but the 
possibility of producing highly enriched populations of thymocyte precursors 
which respond to  the thymic peptide,  thymopoietin (7), should facilitate its 
resolution. 
The relationship  of the  prothymocyte to  the  multipotential hematopoietic 
stem cell also remains to be explored. Although minor differences in density 
distribution and susceptibility to self-sterilization with [3H]TdR can be demon- 
strated,  no physical separation of these cells has been achieved.  We do not 
believe them to be identical. The data is best explained by assuming that they 
are related to each other, either as parent and progeny, or as the offspring of a 
common progenitor. The fact that both can be eliminated by anti-mouse brain 
antisera which have been absorbed by thymus is  intriguing,  but  given the 
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present on both cells.  A  major distinguishing feature between prothymocytes 
and  CFUs  is  the  fact that  the former can  be  induced to  express  thymocyte 
differentiation antigens without influencing the number or distribution of the 
latter (51). 
We have already noted that thymic hormone-responsive cells are capable of 
repopulating the thymus. It is not certain that all cells capable of repopulating 
the thymus are inducible with thymic hormones. If the prothymocytes in spleen 
or BM cell preparations are induced to express the Thy-1 antigen by thymopoie- 
tin and then eliminated with anti-Thy-1 antisera, thymic repopulation is re- 
tarded but not eliminated (reference 8; and Basch and Goldstein, unpublished 
results).  There thus appears to be another stem cell compartment capable  of 
either replacing or replenishing the prothymocyte pool. This population can be 
detected in our repopulation assay. The kinetics of repopulation indicate that 
they make a  negligible contribution to the early phases  of repopulation, but 
their role in other aspects of thymic development remains to be assessed. 
Summary 
The properties of hematopoietic cells which serve as the precursors of cortical 
thymocytes in irradiated reconstituted mice have been described. These cells 
have been termed "prothymocytes."  They are 10- to 15-t~m diameter cells of low 
buoyant density. They are nonadherent to glass wool and more resistant to the 
lytic effects of steroids and ~/-irradiation than their progeny. They lack detecta- 
ble amounts of the surface markers associated with either B or T cells but do 
bear at least two antigens recognized by antisera to mouse brain. 
Discussion with Doctors Gideon Goldstein  and Michael  Lamm have proved invaluable to us. The 
excellent technical assistance of Bohumila Fahmy, Thomas Panagiotatos, and Shirley Carchi 
greatly facilitated this work. 
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